Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
LTR Pharma Limited ( (AU:LTP) ) just unveiled an announcement.
LTR Pharma Limited has announced a change in the director’s interest, specifically involving Julian Chick. The company issued 1,000,000 unlisted options to Julian Chick under the Employee Incentive Plan, as approved by shareholders at the 2025 Annual General Meeting. This move reflects the company’s ongoing efforts to align its leadership’s interests with its strategic goals, potentially impacting its operational focus and shareholder value.
More about LTR Pharma Limited
Average Trading Volume: 848,857
Technical Sentiment Signal: Sell
Current Market Cap: A$88.08M
Learn more about LTP stock on TipRanks’ Stock Analysis page.